Literature DB >> 20021216

Ephrin expression and function in cancer.

Jennifer K McCarron1, Brett W Stringer, Bryan W Day, Andrew W Boyd.   

Abstract

Ephrins are cell membrane-associated signaling proteins bound by transmembrane Eph receptors on juxtaposed cells. Eph-ephrin interactions result in bidirectional signaling within both receptor- and ligand-bearing cells, with diverse consequences for cell morphology and behavior. Such interactions are especially important during early vertebrate development, and growing evidence has revealed equally important roles in adult-tissue homeostasis. As for the Eph receptors, abnormal expression of ephrins is associated with disease, especially cancer. The ephrins have received less attention than the Ephs in the literature, owing, in part, to their later discovery and that they are fewer in number. Here, we attempt to redress this imbalance and provide an 'ephrin-centric' discussion of the expression and function of ephrins in cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20021216     DOI: 10.2217/fon.09.146

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  11 in total

Review 1.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

2.  Design and synthesis of small molecule agonists of EphA2 receptor.

Authors:  Aaron Petty; Nethrie Idippily; Viharika Bobba; Werner J Geldenhuys; Bo Zhong; Bin Su; Bingcheng Wang
Journal:  Eur J Med Chem       Date:  2017-10-10       Impact factor: 6.514

3.  Dimeric small molecule agonists of EphA2 receptor inhibit glioblastoma cell growth.

Authors:  Cody M Orahoske; Yaxin Li; Aaron Petty; Fatma M Salem; Jovana Hanna; Wenjing Zhang; Bin Su; Bingcheng Wang
Journal:  Bioorg Med Chem       Date:  2020-07-25       Impact factor: 3.641

4.  A quantitative LC-MS/MS method for determination of a small molecule agonist of EphA2 in mouse plasma and brain tissue.

Authors:  Bo Zhong; Yaxin Li; Nethrie Idippily; Aaron Petty; Bin Su; Bingcheng Wang
Journal:  Biomed Chromatogr       Date:  2019-01-16       Impact factor: 1.902

5.  Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarction.

Authors:  Wesley T O'Neal; William F Griffin; Jessica L Dries-Devlin; Susan D Kent; Jin Chen; Monte S Willis; Jitka A I Virag
Journal:  Med Hypotheses       Date:  2013-04-04       Impact factor: 1.538

6.  Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathy.

Authors:  Wesley T O'Neal; William F Griffin; Susan D Kent; Filza Faiz; Jonathan Hodges; Jackson Vuncannon; Jitka A I Virag
Journal:  Front Physiol       Date:  2014-04-24       Impact factor: 4.566

7.  A review on Eph/ephrin, angiogenesis and lymphangiogenesis in gastric, colorectal and pancreatic cancers.

Authors:  Julia Rudno-Rudzińska; Wojciech Kielan; Ewelina Frejlich; Krzysztof Kotulski; Wojciech Hap; Krzysztof Kurnol; Przemysław Dzierżek; Marcin Zawadzki; Agnieszka Hałoń
Journal:  Chin J Cancer Res       Date:  2017-08       Impact factor: 5.087

8.  EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice.

Authors:  K'Shylah S Whitehurst; Victoria A Chan; Heather K Estes; Smrithi Valsaraj; Susan Kent; Uma M Sharma; R Christopher Chase; Maliha Bhuiyan; Jitka A I Virag
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 9.  Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity.

Authors:  Thayer K Darling; Tracey J Lamb
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

10.  Inhibition of Ephrin B3-mediated survival signaling contributes to increased cell death response of non-small cell lung carcinoma cells after combined treatment with ionizing radiation and PKC 412.

Authors:  S Ståhl; V O Kaminskyy; G Efazat; A Hyrslova Vaculova; S Rodriguez-Nieto; A Moshfegh; R Lewensohn; K Viktorsson; B Zhivotovsky
Journal:  Cell Death Dis       Date:  2013-01-10       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.